Literature DB >> 19328724

Radiofrequency ablation and biopsy of metastatic pheochromocytoma: emphasizing safety issues and dangers.

Mark D Mamlouk1, Eric vanSonnenberg, Gregory Stringfellow, Dean Smith, Albert Wendt.   

Abstract

The authors report a case of the safe performance of radiofrequency (RF) ablations and biopsies in a patient with metastatic pheochromocytoma. The patient had previously undergone RF ablation at another institution for a tumor in her liver; that procedure was complicated by a hypertensive crisis and cardiac arrest. Our experience emphasizes that, despite a prior life-threatening complication, careful pre-, intra-, and postprocedural care to avoid a hypertensive crisis allowed safe RF ablations and biopsies in a patient with pheochromocytoma.

Entities:  

Mesh:

Year:  2009        PMID: 19328724     DOI: 10.1016/j.jvir.2009.01.031

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  4 in total

Review 1.  Percutaneous ablation of adrenal tumors.

Authors:  Aradhana M Venkatesan; Julia Locklin; Damian E Dupuy; Bradford J Wood
Journal:  Tech Vasc Interv Radiol       Date:  2010-06

Review 2.  Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

Authors:  Victoria L Martucci; Karel Pacak
Journal:  Curr Probl Cancer       Date:  2014-01-15       Impact factor: 3.187

3.  Radiofrequency ablation of metastatic pheochromocytoma.

Authors:  Aradhana M Venkatesan; Julia Locklin; Edwin W Lai; Karen T Adams; Antonio Tito Fojo; Karel Pacak; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2009-11       Impact factor: 3.464

4.  Efficacy and Safety of Ablative Therapy in the Treatment of Patients with Metastatic Pheochromocytoma and Paraganglioma.

Authors:  Jacob Kohlenberg; Brian Welch; Oksana Hamidi; Matthew Callstrom; Jonathan Morris; Juraj Sprung; Irina Bancos; William Young
Journal:  Cancers (Basel)       Date:  2019-02-07       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.